Voyageur Pharmaceuticals Ltd.
VYYRF
$0.13
$0.0218.90%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.24M | -1.55M | -1.58M | -1.25M | -1.13M |
| Total Depreciation and Amortization | 900.00 | 1.00K | 1.10K | 1.20K | 1.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 718.10K | 598.20K | 575.70K | 387.00K | 381.10K |
| Change in Net Operating Assets | -209.90K | -107.80K | -13.30K | 676.10K | 530.10K |
| Cash from Operations | -1.73M | -1.06M | -1.01M | -187.60K | -213.00K |
| Capital Expenditure | -153.80K | -110.10K | -123.50K | -121.80K | -120.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -153.80K | -110.10K | -123.50K | -121.80K | -120.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.33M | 1.71M | 1.62M | 499.20K | 499.20K |
| Repurchase of Common Stock | -- | -- | -5.60K | -5.60K | -18.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 262.40K | 331.10K | 397.00K | 87.80K | -28.90K |
| Cash from Financing | 2.56M | 1.43M | 1.41M | 430.80K | 336.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Net Change in Cash | 675.30K | 256.20K | 267.90K | 121.40K | 3.40K |